Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$333,999,305
-$39,346,833 QoQ
Shares Held
5,506,996
-20.4% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 98.32769081364867.ToString("F0")%
None 1.6723091863513246.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $38,477,015,517 across 12 Drug Manufacturers - General names. BMY ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,427,061 | $12,349,807,890 | |
| 2 | MRK |
Merck & Co., Inc.
|
84,314,971 | $10,142,247,857 | |
| 3 | JNJ |
Johnson & Johnson
|
20,075,375 | $4,907,224,662 | |
| 4 | AZN |
Astrazeneca PLC
|
23,751,085 | $4,684,188,978 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,537,991 | $1,886,789,800 | |
| 6 | ABBV |
AbbVie Inc.
|
6,897,816 | $1,500,205,997 | |
| 7 | PFE |
Pfizer Inc
|
49,916,961 | $1,401,668,262 | |
| 8 | GSK |
GSK plc
|
11,717,613 | $646,695,059 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $333,999,305 | 5,506,996 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $373,346,138 | 6,921,508 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $773,737,808 | 17,156,049 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,195,363,192 | 25,823,357 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,447,197,736 | 23,728,443 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $338,087,680 | 5,977,505 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,770,725 | 150,188 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,923,299 | 166,706 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,564,387 | 287,007 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $221,789,116 | 4,322,532 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $264,569,765 | 4,558,404 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $294,095,369 | 4,598,833 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $320,794,470 | 4,628,401 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $641,757,159 | 8,919,488 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,373,407,609 | 33,385,956 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,753,535,015 | 35,760,195 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,105,386,038 | 42,522,060 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,126,697,807 | 50,147,519 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,686,753,723 | 45,407,364 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,937,611,665 | 43,963,060 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,706,927,214 | 42,878,619 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,837,467,751 | 45,743,475 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,254,961,054 | 53,988,407 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,742,724,192 | 63,651,772 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,208,830,464 | 75,508,261 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||